These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 24548821)
1. Clinical evidence of statin therapy in non-dyslipidemic disorders. Ferri N; Corsini A Pharmacol Res; 2014 Oct; 88():20-30. PubMed ID: 24548821 [TBL] [Abstract][Full Text] [Related]
2. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering. Pedersen TR Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729 [TBL] [Abstract][Full Text] [Related]
3. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin. Breuer HW Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448 [TBL] [Abstract][Full Text] [Related]
4. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting. Cziraky MJ; Watson KE; Talbert RL J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic Roles of Statins in Gynecology and Obstetrics: The Current Evidence. Zeybek B; Costantine M; Kilic GS; Borahay MA Reprod Sci; 2018 Jun; 25(6):802-817. PubMed ID: 29320955 [TBL] [Abstract][Full Text] [Related]
8. Pleiotropic effects of statins and related pharmacological experimental approaches. Alegret M; Silvestre JS Methods Find Exp Clin Pharmacol; 2006 Nov; 28(9):627-56. PubMed ID: 17200729 [TBL] [Abstract][Full Text] [Related]
9. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention? Mora S; Ridker PM Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935 [TBL] [Abstract][Full Text] [Related]
14. HMG CoA reductase inhibitors (statins): do they have a role in age-related macular degeneration? Guymer RH; Chiu AW; Lim L; Baird PN Surv Ophthalmol; 2005; 50(2):194-206. PubMed ID: 15749309 [TBL] [Abstract][Full Text] [Related]
15. Current questions regarding the use of statins in patients with coronary heart disease. Rallidis LS; Lekakis J; Kremastinos DT Int J Cardiol; 2007 Nov; 122(3):188-94. PubMed ID: 17399827 [TBL] [Abstract][Full Text] [Related]
16. Statins: potential new indications in inflammatory conditions. Endres M Atheroscler Suppl; 2006 Apr; 7(1):31-5. PubMed ID: 16503422 [TBL] [Abstract][Full Text] [Related]
19. Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials? Ray KK; Cannon CP; Ganz P Am J Cardiol; 2006 Dec; 98(11A):18P-25P. PubMed ID: 17126675 [TBL] [Abstract][Full Text] [Related]
20. The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in cardiovascular disease: a comprehensive review. Mihos CG; Salas MJ; Santana O Cardiol Rev; 2010; 18(6):298-304. PubMed ID: 20926939 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]